Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs THYROCARE TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS THYROCARE TECHNOLOGIES KRSNAA DIAGNOSTICS/
THYROCARE TECHNOLOGIES
 
P/E (TTM) x - 28.7 - View Chart
P/BV x 10.1 13.8 73.4% View Chart
Dividend Yield % 0.0 2.3 -  

Financials

 KRSNAA DIAGNOSTICS   THYROCARE TECHNOLOGIES
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
THYROCARE TECHNOLOGIES
Mar-21
KRSNAA DIAGNOSTICS/
THYROCARE TECHNOLOGIES
5-Yr Chart
Click to enlarge
High RsNA1,212 0.0%   
Low RsNA485 0.0%   
Sales per share (Unadj.) Rs998.893.6 1,067.7%  
Earnings per share (Unadj.) Rs284.521.4 1,328.5%  
Cash flow per share (Unadj.) Rs342.127.1 1,260.4%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Avg Dividend yield %NM2.9- 
Book value per share (Unadj.) Rs355.580.3 442.9%  
Shares outstanding (eoy) m6.5052.87 12.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x09.1 0.0%   
Avg P/E ratio x039.6 0.0%  
P/CF ratio (eoy) x031.3 0.0%  
Price / Book Value ratio x010.6 0.0%  
Dividend payout %0116.7 0.0%   
Avg Mkt Cap Rs m044,869 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m296581 50.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,4924,946 131.3%  
Other income Rs m122124 98.4%   
Total revenues Rs m6,6155,071 130.5%   
Gross profit Rs m3,4661,713 202.4%  
Depreciation Rs m374303 123.6%   
Interest Rs m2599 2,981.6%   
Profit before tax Rs m2,9551,525 193.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105393 281.1%   
Profit after tax Rs m1,8491,132 163.3%  
Gross profit margin %53.434.6 154.2%  
Effective tax rate %37.425.8 145.1%   
Net profit margin %28.522.9 124.4%  
BALANCE SHEET DATA
Current assets Rs m2,4812,381 104.2%   
Current liabilities Rs m1,838951 193.3%   
Net working cap to sales %9.928.9 34.3%  
Current ratio x1.42.5 53.9%  
Inventory Days Days25107 23.2%  
Debtors Days Days4133 123.6%  
Net fixed assets Rs m3,5643,020 118.0%   
Share capital Rs m2,489529 470.7%   
"Free" reserves Rs m-1783,715 -4.8%   
Net worth Rs m2,3104,243 54.4%   
Long term debt Rs m1,6800-   
Total assets Rs m6,0455,402 111.9%  
Interest coverage x12.4176.3 7.0%   
Debt to equity ratio x0.70-  
Sales to assets ratio x1.10.9 117.3%   
Return on assets %34.921.1 165.1%  
Return on equity %80.026.7 300.0%  
Return on capital %80.536.2 222.8%  
Exports to sales %00-   
Imports to sales %00.7 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA33 0.0%   
Fx inflow Rs m052 0.0%   
Fx outflow Rs m033 0.0%   
Net fx Rs m018 0.0%   
CASH FLOW
From Operations Rs m1,0261,160 88.4%  
From Investments Rs m-611-502 121.7%  
From Financial Activity Rs m308-616 -50.1%  
Net Cashflow Rs m72342 1,704.2%  

Share Holding

Indian Promoters % 27.4 71.2 38.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.2 18.7 193.5%  
FIIs % 6.0 12.1 49.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 28.8 252.3%  
Shareholders   75,554 62,936 120.0%  
Pledged promoter(s) holding % 0.0 100.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   DR LALCHANDANI LABS  AASHKA HOSPITALS  SONI MEDICARE  CHENNAI MEENAKSHI   CHOKSI LAB.  



Today's Market

5 Reasons Why Sensex Slumped 949 Points Today(Closing)

Indian share markets witnessed huge selling pressure today and ended deep in the red.

Related Views on News

THYROCARE TECHNOLOGIES 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of THYROCARE TECHNOLOGIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of THYROCARE TECHNOLOGIES. Also includes updates on the valuation of THYROCARE TECHNOLOGIES.

What Led to the Recent Surge in Shares of Thyrocare Technologies? (Views On News)

Jun 26, 2021

Shares of Thyrocare Technologies rallied over 7% and touched an all time high of Rs 1,465 on the BSE yesterday.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Dec 6, 2021 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS 8-QTR ANALYSIS

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS